164 related articles for article (PubMed ID: 22564689)
1. [Development of mupirocin resistance during eradication treatment of methicillin resistant Staphylococcus aureus carriage].
Kirk KF
Ugeskr Laeger; 2012 May; 174(19):1310-1. PubMed ID: 22564689
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus.
Caffrey AR; Quilliam BJ; LaPlante KL
J Hosp Infect; 2010 Nov; 76(3):206-10. PubMed ID: 20846747
[TBL] [Abstract][Full Text] [Related]
3. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.
Ammerlaan HS; Kluytmans JA; Berkhout H; Buiting A; de Brauwer EI; van den Broek PJ; van Gelderen P; Leenders SA; Ott A; Richter C; Spanjaard L; Spijkerman IJ; van Tiel FH; Voorn GP; Wulf MW; van Zeijl J; Troelstra A; Bonten MJ;
J Antimicrob Chemother; 2011 Oct; 66(10):2418-24. PubMed ID: 21719471
[TBL] [Abstract][Full Text] [Related]
4. Mupirocin resistance in clinical isolates of staphylococci in a tertiary care centre in south India.
Oommen SK; Appalaraju B; Jinsha K
Indian J Med Microbiol; 2010; 28(4):372-5. PubMed ID: 20966573
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
Askarian M; Zeinalzadeh A; Japoni A; Alborzi A; Memish ZA
Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
[TBL] [Abstract][Full Text] [Related]
6. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.
Ammerlaan HS; Kluytmans JA; Berkhout H; Buiting A; de Brauwer EI; van den Broek PJ; van Gelderen P; Leenders SA; Ott A; Richter C; Spanjaard L; Spijkerman IJ; van Tiel FH; Voorn GP; Wulf MW; van Zeijl J; Troelstra A; Bonten MJ;
J Antimicrob Chemother; 2011 Oct; 66(10):2409-17. PubMed ID: 21719473
[TBL] [Abstract][Full Text] [Related]
7. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study.
Lee AS; Macedo-Vinas M; François P; Renzi G; Schrenzel J; Vernaz N; Pittet D; Harbarth S
Clin Infect Dis; 2011 Jun; 52(12):1422-30. PubMed ID: 21628482
[TBL] [Abstract][Full Text] [Related]
8. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
9. Dynamic of nasal colonization by methicillin-resistant Staphylococcus aureus ST398 and ST1 after mupirocin treatment in a family in close contact with pigs.
Lozano C; Aspiroz C; Lasarte JJ; Gómez-Sanz E; Zarazaga M; Torres C
Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):e1-7. PubMed ID: 20663559
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of methicillin resistant Staphylococcus aureus (MRSA) isolates with high-level mupirocin resistance from patients and personnel in a burn center.
Abbasi-Montazeri E; Khosravi AD; Feizabadi MM; Goodarzi H; Khoramrooz SS; Mirzaii M; Kalantar E; Darban-Sarokhalil D
Burns; 2013 Jun; 39(4):650-4. PubMed ID: 23499497
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore.
Choudhury S; Krishnan PU; Ang B
J Hosp Infect; 2012 Sep; 82(1):56-7. PubMed ID: 22854355
[TBL] [Abstract][Full Text] [Related]
12. Mupirocin resistance.
Patel JB; Gorwitz RJ; Jernigan JA
Clin Infect Dis; 2009 Sep; 49(6):935-41. PubMed ID: 19673644
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from a Malaysian hospital.
Lim KT; Hanifah YA; Mohd Yusof MY; Thong KL
Jpn J Infect Dis; 2010 Jul; 63(4):286-9. PubMed ID: 20657072
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of mupirocin resistance in Staphylococcus aureus.
Hetem DJ; Bonten MJ
J Hosp Infect; 2013 Dec; 85(4):249-56. PubMed ID: 24144552
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
Harbarth S; Liassine N; Dharan S; Herrault P; Auckenthaler R; Pittet D
Clin Infect Dis; 2000 Dec; 31(6):1380-5. PubMed ID: 11096006
[TBL] [Abstract][Full Text] [Related]
16. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital.
Lee AS; Macedo-Vinas M; François P; Renzi G; Vernaz N; Schrenzel J; Pittet D; Harbarth S
J Hosp Infect; 2011 Apr; 77(4):360-2. PubMed ID: 21276638
[No Abstract] [Full Text] [Related]
17. Mupirocin resistance is not an inevitable consequence of mupirocin use.
Talon D; Marion C; Thouverez M; Bertrand X
J Hosp Infect; 2011 Dec; 79(4):366-7. PubMed ID: 21968283
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of methicillin-resistant Staphylococcus aureus-positive clinical culture in nasal carriers after decolonization treatment.
Hernández-Porto M; Castro B; Ramos MJ; Arias A; Aguirre-Jaime A; Lecuona M
Am J Infect Control; 2014 Jul; 42(7):e75-9. PubMed ID: 24855930
[TBL] [Abstract][Full Text] [Related]
19. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report.
Orrett FA
Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.
Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
